Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

Yerel katalogda bu makaleye atıf yapan 22 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States 2022 Atıf 77 · OpenAlex
2. HIGH GRADE GLIOMAS 2012 Atıf 9 · OpenAlex
3. Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins 2024 Atıf 7 · OpenAlex
4. Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins 2024 Atıf 7 · OpenAlex
5. Addressing Africa’s outrageous neurosurgeons deficit: what could the problem be? 2023 Atıf 7 · OpenAlex
6. Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial 2024 Atıf 5 · OpenAlex
7. Central Nervous System Tumors 2019 Atıf 4 · OpenAlex
8. What Does Reduced FDG Uptake Mean in High-Grade Gliomas? 2019 Atıf 3 · OpenAlex
9. Management of Patients with High-Grade Glioma 2014 Atıf 3 · OpenAlex
10. Glioblastome Multiforme Epidemiyolojisi, Tedavi Seçenekleri ve Sağkalım Süresi: Retrospektif Tek Merkezli Çalışma 2021 Atıf 1 · OpenAlex